Caribou Biosciences, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Caribou Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Caribou Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$38.2M, a 161% decline year-over-year.
  • Caribou Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$165M, a 51.3% decline year-over-year.
  • Caribou Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$116M, a 9.08% decline from 2022.
  • Caribou Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$106M, a 58.9% decline from 2021.
  • Caribou Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$67M, a 85.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$116M -$9.66M -9.08% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$106M -$39.4M -58.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$67M -$30.9M -85.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$36.1M -$1.82M -5.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$34.3M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.